ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $25,883,000 | -17.7% | 449,733 | -9.0% | 0.02% | -25.0% |
| Q1 2015 | $31,460,000 | +4.8% | 494,122 | +1.6% | 0.03% | -6.7% |
| Q4 2014 | $30,023,000 | +64.0% | 486,279 | +3.1% | 0.03% | +50.0% |
| Q3 2014 | $18,311,000 | +38.2% | 471,589 | +22.6% | 0.02% | +25.0% |
| Q2 2014 | $13,251,000 | -45.8% | 384,663 | -32.0% | 0.02% | -50.0% |
| Q1 2014 | $24,432,000 | +52.9% | 565,418 | +41.0% | 0.03% | +52.4% |
| Q4 2013 | $15,977,000 | +81.1% | 401,025 | +70.6% | 0.02% | +61.5% |
| Q3 2013 | $8,823,000 | +94.0% | 235,034 | +38.8% | 0.01% | +85.7% |
| Q2 2013 | $4,549,000 | – | 169,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |